Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts

Journal of Neuro-Oncology

Volumn 90, Issue 2, 2008, Pages 181-189

  Lipinski, Christopher A ^a   Tran, Nhan L ^b   Viso, Carole ^a   Kloss, Jean ^a   Yang, Zhongbo ^a   Berens, Michael E ^b   Loftus, Joseph C ^a  

^a MAYO CLINIC   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

FAK; Focal adhesion kinase; Glioma; Invasion; Pyk2; Xenografts

Indexed keywords

FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION KINASE 2; GLIOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSDUCTION, GENETIC;

EID: 53349127325     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9656-8     Document Type: Article

References (32)

1. Stupp R, Gander M, Leyvraz S, Newlands E (2001) Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol 2:552-560. doi: 10.1016/S1470-2045(01)00489-2
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/NEJMoa043330
3. Gladson CL (1999) The extracellular matrix of glioma: Modulation of cell function. J Neuropathol Exp Neurol 58:1029-1040. doi: 10.1097/ 00005072-199910000-00001
4. Nutt CL, Matthews RT, Hockfield S (2001) Glial tumor invasion: A role for the upregulation and cleavage of BEHAB/Brevican. Neuroscientist 7:113-122
5. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046-1069. doi: 10.1016/ j.biocel.2004.01.013
6. Zamir E, Geiger B (2001) Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 114:3583-3590
7. Schlaepfer DD, Mitra SK (2004) Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14:92-101. doi: 10.1016/ j.gde.2003.12.002
8. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV (2000) Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1:31-36. doi: 10.1038/76882
9. Okigaki M, Davis C, Falasca M, Harroch S, Felsenfeld DP, Sheetz MP et al (2003) Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc Natl Acad Sci USA 100:10740-10745. doi: 10.1073/pnas.1834348100
10. Du QS, Ren XR, Xie Y, Wang Q, Mei L, Xiong WC (2001) Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. J Cell Sci 114:2977-2987
11. Zhao J, Zheng C, Guan J (2000) Pyk2 and FAK differentially regulate progression of the cell cycle. J Cell Sci 113:3063-3072
12. Sieg DJ, Ilic D, Jones KC, Damsky CH, Hunter T, Schlaepfer DD (1998) Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK(-) cell migration. EMBO J 17:5933-5947. doi: 10.1093/emboj/17.20.5933
13. Ueki K, Mimura T, Nakamoto T, Sasaki T, Aizawa S, Hirai H et al (1998) Integrin-mediated signal transduction in cells lacking focal adhesion kinase p125FAK. FEBS Lett 432:197-201. doi: 10.1016/S0014-5793(98)00862-X
14. Wang D, Grammer JR, Cobbs CS, Stewart JE Jr, Liu Z, Rhoden R et al (2000) p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo. J Cell Sci 113:4221-4230
15. Hecker TP, Ding Q, Rege TA, Hanks SK, Gladson CL (2004) Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells. Oncogene 23:3962-3971. doi: 10.1038/sj.onc.1207541
16. Lipinski CA, Tran NL, Menashi E, Rohl C, Kloss J, Bay RC et al (2005) The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. Neoplasia 7:435-445. doi: 10.1593/neo.04712
17. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS et al (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7-16. doi: 10.1593/neo.04535
18. Gutenberg A, Bruck W, Buchfelder M, Ludwig HC (2004) Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol 108:224-230. doi: 10.1007/s00401-004-0886-3
19. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P (2006) A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109-116. doi: 10.1038/nmeth846
20. Lipinski CA, Tran NL, Dooley A, Pang YP, Rohl C, Kloss J et al (2006) Critical role of the FERM domain in Pyk2 stimulated glioma cell migration. Biochem Biophys Res Commun 349:939-947. doi: 10.1016/ j.bbrc.2006.08.134
21. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77:8957-8961. doi: 10.1128/JVI.77.16.8957-8951.2003
22. Lipinski CA, Tran NL, Bay C, Kloss J, McDonough WS, Beaudry C et al (2003) Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 1:323-332
23. Zhao JH, Reiske H, Guan JL (1998) Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 143:1997-2008. doi: 10.1083/jcb.143.7.1997
24. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C et al (2007) Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282:14845-14852. doi: 10.1074/jbc.M606695200
25. Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D et al (2007) A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 46:488-496. doi: 10.1002/mc.20297
26. Kohno T, Matsuda E, Sasaki H, Sasaki T (2008) Protein-tyrosine kinase CAKβ/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 α2 helix and thus forming its dimer. Biochem J 410:513-523. doi: 10.1042/BJ20070665
27. Park SY, Avraham HK, Avraham S (2004) RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner. J Biol Chem 279:33315-33322. doi: 10.1074/jbc.M313527200
28. Archakov AI, Govorun VM, Dubanov AV, Ivanov YD, Veselovsky AV, Lewi P et al (2003) Protein-protein interactions as a target for drugs in proteomics. Proteomics 3:380-391. doi: 10.1002/pmic.200390053
29. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275-282. doi: 10.1002/ (SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9
30. Corcoran A, Del Maestro RF (2003) Testing the "go or grow" hypothesis in human medulloblastoma cell lines in two and three dimensions. Neurosurgery 53:174-184. doi: 10.1227/ 01.NEU.0000072442.26349.14
31. Gao CF, Xie Q, Su YL, Koeman J, Khoo SK, Gustafson M et al (2005) Proliferation and invasion: Plasticity in tumor cells. Proc Natl Acad Sci USA 102:10528-10533. doi: 10.1073/pnas.0504367102
32. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL et al (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro-oncol 7:164-176. doi: 10.1215/S1152851704000821